Oncotarget | MTAP loss in metastatic breast cancer patients: Genomic landscape
“In breast cancer, MTAP downregulation activates ornithine decarboxylase (ODC) which in turn leads to formation of putrescine which promotes tumor migration, invasion and angiogenesis .”
BUFFALO, NY- March 14, 2023 – A new research paper was published in Oncotarget's Volume 14 on March 11, 2023, entitled, “Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss.”
Homozygous deletion of methylthioadenosine phosphorylase (MTAP) upregulates de novo synthesis of purine (DNSP) and increases the proliferation of neoplastic cells. This increases the sensitivity of breast cancer cells to DNSP inhibitors such as methotrexate, L-alanosine and pemetrexed. In their recent study, Maroun Bou Zerdan, Prashanth Ashok Kumar, Elio Haroun, Nimisha Srivastava, Jeffrey Ross, and Abirami Sivapiragasam from SUNY Upstate Medical University and Foundation Medicine, Inc. analyzed 7,301 metastatic breast cancer (MBC) patients that underwent hybrid-capture based comprehensive genomic profiling (CGP).
“We provide one of the first large analyses of the spectrum of GA [genomic alterations] occurring in MTAP deleted MBC with the hope that this would enable identifying potential therapeutic agents in the future.”
Tumor mutational burden (TMB) was determined on up to 1.1 Mb of sequenced DNA and microsatellite instability (MSI) was determined on 114 loci. Tumor cell PD-L1 expression was determined by IHC (Dako 22C3). 208 (2.84%) of MBC featured MTAP loss. MTAP loss patients were younger (p = 0.002) and were more frequently ER− (30% vs. 50%; p < 0.0001), triple negative (TNBC) (47% vs. 27%; p < 0.0001) and less frequently HER2+ (2% vs. 8%; p = 0.0001) than MTAP intact MBC.
Lobular histology and CDH1 mutations were more frequent in MTAP intact (14%) than MTAP loss MBC (p < 0.0001). CDKN2A (100%) and CDKN2B (97%) loss (9p21 co-deletion) were significantly associated with MTAP loss (p < 0.0001). Likely associated with the increased TNBC cases, BRCA1 mutation was also more frequent in MTAP loss MBC (10% vs. 4%; p < 0.0001). As for immune checkpoint inhibitors biomarkers, higher TMB >20 mut/Mb levels in the MTAP intact MBC (p < 0.0001) and higher PD-L1 low expression (1–49% TPS) in the MTAP loss MTAP (p = 0.002) were observed.
“MTAP loss in MBC has distinct clinical features with genomic alterations (GA) affecting both targeted and immunotherapies. Further efforts are necessary to identify alternative means of targeting PRMT5 and MTA2 in MTAP-ve cancers to benefit from the high-MTA environment of MTAP-deficient cancers.”
Read the full research paper: DOI: https://doi.org/10.18632/oncotarget.28376
Correspondence to: Abirami Sivapiragasam
Keywords: breast cancer, metastatic, MTAP loss
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
For media inquiries, please contact: firstname.lastname@example.org.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
NEWPORT NEWS, VA – The U.S. Department of Energy’s (DOE) Thomas Jefferson National Accelerator Facility has selected Tim Michalski to lead its Engineering Division as the Engineering Division Manager. In this role, Michalski oversees all aspects of the management and operation of the Engineering Division. The division includes more than 200 staff members and supports the Continuous Electron Beam Accelerator Facility and the lab’s growing project portfolio.
“I am proud to name Tim as our newest Engineering Division Manager,” said Jefferson Lab Director Stuart Henderson. “Tim has ...
In late 2021, Salvatore Torquato, on sabbatical from Princeton’s Department of Chemistry, reached across the aisle as it were and invited a young astrophysicist at the Institute for Advanced Study to apply the tools of statistical mechanics to his own work on the distribution of galaxies.
The astrophysicist, Oliver Philcox, now a postdoc at the Simons Foundation, was intrigued. A year-long collaboration ensued.
The questions at the heart of their unusual partnership were straightforward: can the statistical descriptors Torquato has worked with throughout his career find application in unlikely places like cosmology, and can they accurately characterize the complexity in the distribution ...
Imagine you are a doctor managing the emergency room of a large hospital. You suddenly get a call reporting a mass shooting at a nearby concert. In 20 minutes, you will be responsible for triaging more than 200 patients with a range of injuries. You do not have enough staff or resources and the hospital policies are not designed for a situation this dire.
“When people respond to emergencies, many decisions they face are quite predictable. They’re trained on them, and there’s policy,” said UMass Lowell’s Neil Shortland, associate professor in the School of Criminology and Justice Studies. “But every now and then, they get stuck with a really ...
When astronauts begin to build a permanent base on the moon, as NASA plans to do in the coming years, they’ll need help. Robots could potentially do the heavy lifting by laying cables, deploying solar panels, erecting communications towers, and building habitats. But if each robot is designed for a specific action or task, a moon base could become overrun by a zoo of machines, each with its own unique parts and protocols.
To avoid a bottleneck of bots, a team of MIT engineers is designing a kit of universal ...
A common and widely used chemical may be fueling the rise of the world’s fastest growing brain condition – Parkinson’s disease. For the past 100 years, trichloroethylene (TCE) has been used to decaffeinate coffee, degrease metal, and dry clean clothes. It contaminates the Marine Corps base Camp Lejeune, 15 toxic Superfund sites in Silicon Valley, and up to one-third of groundwater in the U.S. TCE causes cancer, is linked to miscarriages and congenital heart disease, and is associated ...
Brigham researchers studying how and why certain cell types proliferate in the gut found that xanthine, which is found in coffee, tea and chocolate, may play a role in Th17 differentiation
Insights may help investigators better understand gut health and the development of conditions such as inflammatory bowel disease
The gut is home to a cast of microbes that influence health and disease. Some types of microorganisms are thought to contribute to the development of inflammatory conditions, such as inflammatory bowel disease (IBD), but the exact cascade of events that leads from microbes to immune cells to disease remains ...
NEW ORLEANS, La. – Global death rates from aortic diseases have steadily increased over the past two decades. Studies show up to 8% of individuals will develop an aortic aneurysm during their lifetime, higher than rates of colon and lung cancer combined, and over 80% of ruptured aortic aneurysms cause sudden death.
To save lives and improve outcomes for patients with aortic disease of all kinds, Ochsner Health is excited to announce the establishment of The Ochsner Aortic Center. Outfitted with cutting-edge imaging technology that allows medical staff to make faster, easier, and safer decisions, this dedicated, comprehensive aortic center is now the ...
A team of researchers from Aston University has developed a new technique that could be a game changer for the medical and drinks industries.
The technology enables insoluble drug/oil to be dissolved in water. The technique is novel because it doesn’t just mix the two together to make an emulsion, it makes oil soluble in water and has the potential to revolutionise a variety of medical treatments and improve drug delivery.
The technique was developed with Max Bio+ a spin out company founded by Professor Sunil Shah, a consultant ...
ATLANTA — The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) released a summary of its new guideline titled “the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Osteonecrosis Who Have Failed Nonoperative Therapy.” The ACR and AAHKS have worked together before, creating guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty in 2017 and 2022. While those guidelines focus on which medications ...
Researchers from Drexel University have uncovered a novel regulatory mechanism in the brain that is essential for making the right kinds of proteins that promote healthy brain function, and its malfunctioning may be an early contributor of the development of Alzheimer’s disease.
Brain cells are continuously undergoing changes in response to environmental stimuli and to record new memories. Such complex brain capability relies on the ability of brain cells to generate different functional variants of the same protein using a process known as alternative RNA splicing.
Recent studies have reported defects ...
LAST 30 PRESS RELEASES:
[Press-News.org] Oncotarget | MTAP loss in metastatic breast cancer patients: Genomic landscape